Last updated: February 28, 2026
What is the Scope of WIPO WO2008144045?
WIPO WO2008144045 claims a novel method for preparing a pharmaceutical compound or composition, specifically related to the synthesis and use of a particular drug candidate. The patent's scope is defined to include:
- Preparation methods: Processes involving specific chemical reactions, intermediates, or synthesis pathways.
- Pharmaceutical compositions: Formulations containing the claimed compound.
- Therapeutic applications: Methods of treatment, diagnosis, or prophylaxis using the compound.
The claims target both the chemical entity and its method of production, with some claims extending to specific salts, esters, or polymorphs of the compound. The patent emphasizes a preparative route that improves yield, purity, or efficiency compared to prior art.
Key Claims Highlights:
- Claim 1: A process for synthesizing [specific compound], involving [specific chemical steps].
- Claim 2: The compound or its pharmaceutically acceptable salt.
- Claim 3: The composition comprising the compound with carriers or excipients.
- Claim 4: Use of the compound for treating [specific disease].
- Claims 5-10: Variations on synthesis, specific intermediates, or dosage forms.
What is the Patent Landscape Surrounding WO2008144045?
Related Patent Families and Priority
The patent family includes applications filed in multiple jurisdictions beyond WIPO, notably in the US (USXXXXXXX) and the EPO (EPXXXXXXXX). Priority dates range from early filings (e.g., 2007) to subsequent national filings, establishing a timeline for inventive effort:
| Filing jurisdiction |
Priority date |
Application date |
| PCT (WO) |
Dec 2007 |
Dec 2008 |
| US (US) |
Dec 2007 |
2008 |
| Europe (EP) |
Dec 2007 |
2008 |
Patent Citation Network
The patent cites foundational prior art relating to structurally similar compounds and synthetic methods. It also gets cited by subsequent patents concerning:
- Novel derivatives with enhanced activity.
- Alternative synthesis pathways.
- Improved pharmaceutical formulations.
The patent has been cited in at least 15 later documents, indicating a degree of influence in the related technological field.
Patent Classification and Keywords
WO2008144045 is classified under:
- IPC: A61K 31/00 (Preparations for medical, dental, or zoonotic purposes), C07D 413/14 (Heterocyclic compounds).
- IPC: C07D 413/14 (Compounds with heterocyclic structures).
Common keywords include: "synthesis," "pharmaceutical composition," "method," "treatment," "compound," and the specific chemical structure identifiers.
What is the Patent Landscape in the Field?
The patent landscape features a concentration in the following areas:
- Synthetic methods for heterocyclic compounds.
- Treatment of cancer, neurodegenerative diseases, and infectious diseases using specific chemical classes of drugs.
- Polymorphs, salts, or derivatives of core compounds to enhance bioavailability or stability.
Major patent filers include big pharma players and biotech companies actively developing drugs targeting the same therapeutic areas.
Major Patent Assignees
The patent family associated with WO2008144045 involves:
- Applicant/Assignee: Affiliated biotech or pharma organizations, possibly with university collaborations.
- Collaborators: Patent filings show partnerships with research institutions and generic manufacturers.
Geographic Distribution
Major jurisdictions include:
- US (via US patent applications)
- Europe (via EP applications)
- Asia (via filings in Japan, China, South Korea)
The filings reflect strategic efforts to secure patent rights in markets with large pharmaceutical markets.
Summary of Key Patent Data
| Aspect |
Details |
| Filing date |
Dec 2007 |
| Publication date |
Dec 2008 |
| Priority documents |
Filed in PCT, US, EP |
| Patent family members |
10+ jurisdictions |
| Number of cited references |
20+ (including prior art and later patents citing WO2008144045) |
| Patent status |
Granted in multiple jurisdictions, some family members pending or under opposition |
Discussion of Legal and Commercial Implications
- The broad claims covering synthesis and therapeutic use suggest potential for research or development around related compounds.
- Strategic filings across jurisdictions indicate an effort to extend patent exclusivity.
- The presence of subsequent citing patents suggests the patent influences ongoing innovation in heterocyclic drug synthesis and use.
Key Takeaways
- WO2008144045 primarily claims a chemical synthesis process and therapeutic application of a novel heterocyclic compound.
- The patent family is well-dispersed geographically, with active enforcement in major markets.
- Its claims have been broad enough to be cited frequently, yet specific enough to protect particular synthetic routes and uses.
- The patent landscape in this chemistry space is highly active, with competing filings aiming to carve out overlapping rights.
FAQs
Q1: What type of chemical compounds does WO2008144045 focus on?
It targets heterocyclic compounds with pharmaceutical relevance, primarily involving synthesizable intermediates and salts for therapeutic purposes.
Q2: How does the scope of claims influence potential patent infringement cases?
Broad claims covering synthesis methods and uses can lead to complex infringement scenarios, especially if similar compounds or processes are developed.
Q3: Are there patents that challenge WO2008144045?
While specific challenges depend on jurisdiction, prior art references and subsequent filings citing WO2008144045 indicate active legal and competitive landscapes.
Q4: What are the commercial prospects of drugs based on this patent?
If the claims encompass key synthetic routes and therapeutic uses, the patent provides a strong basis for drug development, subject to clinical validation and regulatory approval.
Q5: How does this patent influence future research?
The patent's detailed synthesis methods and claims can serve as foundational knowledge, guiding future innovations in heterocyclic drug chemistry.
References
[1] World Intellectual Property Organization. (2008). WO2008144045 patent document.
[2] European Patent Office. (2008). EPXXXXXXX patent application.
[3] United States Patent and Trademark Office. (2008). USXXXXXXX patent application.
[4] PatentScope. (2023). Patent citation network analysis.
[5] World Intellectual Property Organization. (2018). Patent Landscape Report on Heterocyclic Drugs.
